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In the past few decades, some measures of population risk have improved, while others have deteriorated.
Understanding the health of the population requires integrating these different trends.  We compare
the risk factor profile of the population in the early 1970s with that of the population in the early 2000s
and consider the impact of a continuation of recent trends.  Despite substantial increases in obesity
in the past three decades, the overall population risk profile is healthier now than it was formerly. 
For the population aged 25-74, the 10 year probability of death fell from 9.8 percent in 1971-75 to
8.4 percent in 1999-2002.  Among the population aged 55-74, the 10 year risk of death fell from 25.7
percent to 21.7 percent.  The largest contributors to these changes were the reduction in smoking and
better control of blood pressure.  Increased obesity increased risk, but not by as large a quantitative
amount.  In the future, however, increased obesity may play a larger role than continued reductions
in smoking.  We estimate that a continuation of trends over the past three decades to the next three
















Departments of Internal Medicine and
Health Policy and Management
University of Michigan
300 North Ingalls, Suite 7E10
Ann Arbor, MI 48109
abrosen@umich.edu 
Understanding changes in population health is a key input into public and private 
decision-making.  People who live longer have more years of life to enjoy, but also need 
to prepare for more older years, through increased saving and possibly delayed 
retirement.  Rational decision-makers will take into account forecasts of longevity and 
quality of life in making their work and savings decisions.  Public policy must account 
for this as well.  Every additional year of life after age 65 is associated with about 
$15,000 of social security and medical care spending, and years spent disabled result in 
substantially greater medical spending than years spent without disability (Trends in 
Health and Aging, 2007).  
Health outcomes are a product of several inputs.  Peoples’ behaviors and genetic 
predisposition put them at risk for disease.  The medical system then alleviates or treats 
these risks.  Distinguishing the role of behavioral risk factors from medical care is 
important, for several reasons.  One reason is the impact on medical spending.  Improved 
behaviors generally lower medical spending, at least in the short term, while treating 
adverse risk profiles increases costs.  Thus, knowing whether health behaviors are 
improving is important in forecasting medical costs.  In addition, behavioral trends are 
essential in predicting future disease burden.  A population that behaves in a healthier 
way will have higher quality of life compared to one with a more adverse behavioral 
profile, even given length of life.  Finally, changes in behaviors are a good guide to the 
‘demand’ for better health, which can be used to develop models of health demand and 
supply.  In this paper, we consider what has happened to the population’s health 
behaviors over time, and consider various scenarios for trends in the future.      2
Past trends in behavioral risk factors have not been in a common direction.  Some 
measures of population risk have improved markedly, while others have deteriorated.  
Smoking rates have fallen by more than a third since 1960 (Anonymous, 1999) and 
alcohol consumption has declined by 20 percent since 1980 (Lakins, Williams, and Yi, 
2006), both leading to better health.  Demographically, the population is better educated, 
and better educated people live longer than less educated people (Elo and Preston, 1996).  
On the other hand, obesity rates have doubled in the past two decades (Flegal et al., 2002) 
and diabetes has increased as a result (Gregg et al., 2005).  Further, the population has a 
higher share of minority groups, for whom life expectancy is lower.  The net impact of 
these risk factor trends on population health expectations is uncertain (Preston, 2005).   
Our analysis has two parts.  We start by aggregating these different health trends 
into a single measure of population risk.  We focus on the most common risk factors: 
smoking, drinking, obesity, hypertension, high cholesterol, and diabetes.  We weight the 
different risk factors by their impact on predicted 10 year mortality, as determined 
through multiple regression analysis.  We show that overall health trends in the past three 
decades have improved markedly.  For the entire population aged 25 and older, the age-
adjusted probability of dying in 10 years, conditional on the same level of medical care, 
fell from 9.8 percent in the early 1970s to 8.4 percent around 2000, a 14 percent 
reduction.  The largest contributors to this trend were reductions in smoking and 
improved blood pressure control.   
The second part of our analysis considers the impact of a continuation of future 
trends.  Our conclusions here are not as rosy.  We show that if current obesity trends 
continue, the population mortality risk could increase, even with continued reductions in   3
smoking.  We estimate that about a third of the past gains would be reversed within 20 
years.  The increase in obesity is the proximate cause of this.  But even given the increase 
in obesity, the health impact would be substantially blunted if more people took 
medication to control blood pressure, cholesterol, and diabetes.   
Our paper has five sections.  The first section discusses important risk factors; the 
second section shows trends in risk factors.  The third section evaluates mortality risk 
from the early 1970s through the early 2000s.  The fourth section then considers 
alternative scenarios for future risk trends.  The last section concludes.   
 
I.  Health Behaviors  
We are interested in measuring the population’s health profile over time.  Health 
is a product of many features: the individual risk factor profile; the disease environment; 
and the impact of medical care.  We focus on individual behaviors, since that is (perhaps) 
the easiest to forecast, and tells us the most about the demand for health. 
To understand our analysis, consider a simple model.  Individuals live for up to 
two periods; health is defined as the probability that a person survives to period 2.  If 
alive, people get consumption c.  For simplicity, we assume no borrowing or lending, and 
no discounting.  The lifetime utility function is then: 
 
  V = U(c)  +  π(b) · U(c).       ( 1 )  
 
Where π (b) is the probability of survival to period 2, depending on behavior b.  Define 
the behavior as improving health, so π´ > 0.  Action b has a cost, p per unit.  The cost   4
may be monetary (the cost of a gym membership) or psychological (the implicit cost of 
dieting).  In equilibrium, people will consume item b until the marginal benefit is equal to 
the marginal cost.  This is given by: 
 
π´ · U(c) = p         ( 2 )  
 
 Equilibrium  b will change over time for two reasons.  The first is that the 
population becomes richer.  This shows up as increasing c.  As long as people are not 
sated in goods consumption, increases in income will raise the utility of living longer, and 
hence lead to a greater investment in b.  The second change is in the cost of better health.  
This cost may increase or decrease over time.  To the extent that b involves hiring people 
(e.g., a personal trainer), and all wages increase in the economy, the cost of b will 
increase.  Some aspects of technical change will also increase b.   For example, 
technology that makes food more readily available will increase the psychological cost of 
denying ourselves food.  Cutler, Glaeser, and Shapiro (2003) suggest that this is why 
obesity has increased over time.  In other cases, b might fall over time, as we develop 
new medications or ways of improving health.   
  The net impact of economic changes on health behaviors is thus indeterminate, 
depending on the demand for better health relative to the cost of health improvements. 
Empirically, we delineate the risk factors we consider into four groups: 
demographics, genetics, behaviors and biological factors.  The relations between these 
are shown in Figure 1.  Demographic factors included age, sex, race, and education.  Age, 
sex, and race are standard risk measures.  Education is strongly related to health, although   5
the reason for this is unclear (Cutler and Lleras-Muney, 2006).  Since some evidence 
suggests that the education effect is causal (Lleras-Muney, 2005; Oreopoulos, 2005; 
Arendt, 1005; Spasojevic, 2003), we consider this as a demographic risk factor.  Of 
course, to the extent that education reflects other underlying characteristics of people 
such as position in the social hierarchy (Wilkinson, 1996; Link and Phelan, 1995) or 
discount rates (Fuchs, 1982), we will be overstating the impact of educational changes on 
health. 
A variety of genetic factors predispose people to disease.  The data that we have 
do not render genetic profiles.  Since it is unlikely that the population’s genetic profile 
would change markedly in a few decades – particularly controlling for gender and race – 
we do not consider the possible impact of genetic changes. 
  There are a number of behavioral risk factors that are important for health.  
Mokdad et al. (2004) rank the impact of risk factors on mortality; our results largely 
confirm these rankings.  The most important behavioral risk factor is smoking.  Mokdad 
et al. estimate that smoking accounts for about 435,000 deaths annually.  Obesity is 
second in importance, though the impact is controversial (Flegal et al., 2005; Willett et 
al., 2005).  The impact of obesity on mortality ranges from about 100,000 deaths per year 
to about 400,000 deaths per year.   
Other behaviors are of much less quantitative importance than smoking and 
obesity.  Excessive alcohol use is the third important risk factor, accounting for 85,000 
deaths.  Remaining risk factors include exposure to microbial agents (75,000 deaths) or 
toxic agents (55,000 deaths), motor vehicle accidents (43,000 deaths), guns (29,000 
deaths), sexual behaviors (20,000 deaths), and illicit drug use (17,000 deaths).  Many of   6
these latter risk factors disproportionately affect the young.  For purposes of Social 
Security and Medicare, our focus is primarily on the elderly.  Thus, we limit our analysis 
of behavioral risks to smoking, obesity, and alcohol use. 
Finally, we consider two biological risk factors: blood pressure and cholesterol.  
Both blood pressure and cholesterol are products of other behaviors, most importantly 
obesity.  We consider this link extensively in our forecasting analysis.   
Not all important risk factors are included in our analysis of risk.   For example, 
the composition of diet matters as well as overall caloric intake.  Among biological risks, 
the most important omissions are hemoglobin A1c (i.e. diabetes status) and some of the 
more novel risk factors (such as C-reactive protein or albuminuria).  None of these risk 
factors were measured in the early NHANES.   
 
II. Data 
Risk factor analysis requires data on physical measures of the population, not just 
self-reports.  Not everyone with high blood pressure knows they are hypertensive, for 
example, and the share of people with this knowledge will change over time.  In the US, 
the leading survey with both physical examination and laboratory measurements is the 
National Health and Nutrition Examination Survey, or NHANES.  More detail on the 
survey design and operation is reported elsewhere (Miller, 1973; NCHS, 2006).  
We use two NHANES surveys, the first from 1971-75 (NHANES I), and the 
second from 1999-2002 (NHANES IV).  Our analysis began with the NHANES I 
because that is the first population health survey that asked about smoking status, a key 
variable in health risk.     7
In each case, our initial sample is the population aged 25-74.  The upper age 
restriction matches the sampling frame of NHANES I.  To focus on the elderly and non-
elderly population in specific, we also consider the population aged 55 and older. 
Table 1 shows the characteristics of the sample in the two time periods.  The first 
set of columns are for the entire population, and the second set of columns are restricted 
to the population aged 55 and older.  After eliminating people with missing risk factor 
information, our full age sample includes 6,764 respondents to NHANES I and 6,255 
respondents to NHANES IV.  The subset of older respondents is about one-third the size. 
Age was categorized into 10 year age groups beginning at age 25.  Race was 
defined as white, black, or other.  Education was divided into three groups: less than a 
high school degree; a high school degree; and at least some college.  Table 1 shows that 
these risk factors moved in the expected direction over time.  In particular, the share of 
people with at least some college education doubled over those three decades. 
  Following standard practice in the literature, smoking status was divided into 
three groups: current smokers, former smokers, and never smokers.  Smoking status was 
determined by responses to two questions, “Have you ever smoked at least 100 cigarettes 
in your entire life?” and “Do you smoke cigarettes now?” The share of current smokers 
fell by a third over the time period, from 40 percent in the early 1970s to 25 percent 
around 2000.  Two-thirds of this was people who never started smoking, and one-third 
was people quitting.   
  Drinking status was divided into heavy drinkers, light drinkers, and non drinkers.  
In NHANES I, drinking status was assessed with three questions.  Non-drinkers were 
those who answered “no” to the question, “During the past year have you had at least one   8
drink of beer, wine, or liquor?”  Among those who answered “yes”, subsequent questions 
included “How often do you drink?” and “When you drink, how much do you usually 
drink over 24 hours?”  Heavy drinkers were those who drink 3 or more drinks over 24 
hours and reported drinking “everyday” or “just about everyday”.  The next possible 
response was “about 2 or 3 times a week”.  In NHANES IV, non-drinkers were defined 
as those who responded “zero” to the question, “In the past 12 months, how often did you 
drink any type of alcoholic beverage?”  A subsequent question asked people, “In the past 
12 months, on those days that you drank alcoholic beverages, on the average how many 
drinks did you have?”  Heavy drinkers were those who reported drinking three or more 
drinks at least four times per week (i.e., four or more times per week, 16 or more times 
per month, or 208 or more times per year).  Both heavy and light alcohol use declined 
over time.  Heavy drinking fell from 7 to 4 percent of the population; light drinking fell 
from 72 to 65 percent.   
BMI was based on direct measurement of height and weight.  In accordance with 
conventional guidelines (National Institutes of Health, 1998), we classified respondents 
as underweight (BMI<18.5), normal weight (18.5≤BMI<25), overweight (25≤BMI<30) 
and obese (30≤BMI).  The largest change in weight has been the shift from healthy 
weight to overweight.  Overweight and obesity were 49 percent of the population in the 
early 1970s; today, they are 68 percent.  At the other end of the scale, fewer people are 
underweight now than in the past (2 percent versus 3 percent).   
Blood pressure and total cholesterol were measured according to standard 
protocols used in the medical examination component of each survey (Burt et al., 1995; 
Hajjar and Kotchen, 2003; Carroll et al., 2005).  Blood pressure was divided into four   9
groups following the recommendations of the seventh report of the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 
(JNC VII):
15 normal blood pressure (systolic blood pressure (SBP) ≤ 120 mmHG and 
diastolic blood pressure (DBP) ≤ 80 mmHG); pre-hypertension (120≤ SBP<140 or 80≤ 
DBP<90); stage 1 hypertension (140≤ SBP<160 or 90≤ DBP<100); and stage 2 
hypertension (160≤ SBP or 100≤ DBP).  Cholesterol levels were divided into three 
groups based on the recommendations of the Third Report of The National Cholesterol 
Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood 
Cholesterol in Adults (NCEP, 2001): normal cholesterol (total cholesterol<200); 
borderline high cholesterol (200≤total cholesterol<240); and high cholesterol (240≤ total 
cholesterol). 
Even with the increase in obesity, substantial gains have been made in blood 
pressure and cholesterol control.  The share of people with stage 2 hypertension fell from 
16 percent of the population in the early 1970s to 5 percent around 2000.  The share with 
stage 1 hypertension fell nearly in half as well.  Rates of high cholesterol declined by 
over one-third, almost certainly a result of improved medications. 
 
III.  The Health Profile, 1971-75 vs. 1999-2002 
  To gauge the impact of these differing health trends, we need to weight the 
various risk factors.  The optimal weights to use will depend on the question being asked.  
One could use longevity weights, quality of life weights, or medical spending weights.  In 
practice, the NHANES does not have data on medical spending, and quality of life data 
are not great.  Thus, we use mortality weights.     10
  To estimate the impact of these risk factors on mortality, we use the 
epidemiological follow-up conducted as part of the 1971-75 NHANES.  Epidemiological 
follow-ups were conducted at periodic intervals after the initial survey, going into the 
1990s.  We estimated a logit model for death from any cause within the 10 years 
subsequent to the initial survey.  We choose 10 years to get the long-term impact of these 
risk factors, but to avoid a situation where most everyone will have died.  Previous 
evidence shows that prediction equations from NHANES are broadly similar to those 
from other data sources such as the Framingham Heart Study, with the possible exception 
of increased importance of smoking and diabetes in NHANES data (Liao et al., 1999; 
Leaverton et al., 1987).   
  Table 2 shows the odds ratios for death in the subsequent 10 years.  The 
coefficients are all in the expected direction, and most are statistically significant.  
Among demographic factors, blacks are more likely to die than whites (OR=1.4; p=.010), 
and marriage is protective of future longevity (OR=0.68; p=.001).  People with less than 
a high school degree have 27 percent higher mortality than people with a high school 
degree (p=.036).   
  Behavioral risk factors are also important.  Being a current smoker increases the 
odds of death in the next 10 years by 113 percent (p<.001).  Heavy drinking is associated 
with higher mortality, and light drinking is associated with lower mortality; the net 
impact is thus unclear, though as we show below, these changes are relatively small. 
Without controlling for hypertension or high cholesterol, obesity increases the 
odds of death by 44 percent (p=.018), however this drops to 28 percent and is no longer 
statistically significant (p=.112) once blood pressure and cholesterol are controlled for.    11
This finding parallels other research from the Framingham Heart Study, which does not 
include obesity in the risk equations (Anderson et al., 1991; Wilson et al., 1998), and data 
showing that the impact of obesity on mortality is declining in more recent surveys 
(Flegal et al., 2005).  Indeed, it is likely that some of the obesity effect we find would be 
reduced still further if we were able to control for diabetic status.  Being underweight is 
associated with significantly higher mortality, likely because of the loss of lean body 
mass (and, therefore, weight) associated with chronic and/or severe illnesses (Willett et 
al., 2005).   
Both hypertension and high cholesterol are associated with substantially increased 
risk.  People with stage 2 hypertension have a 54 percent increase in risk (p=.023) above 
those with normal blood pressure.  High cholesterol is associated with a 15 percent higher 
mortality risk, though this is not statistically significant (p=.277).   
We use these coefficients to estimate the mortality risk for every person in the 
1971-75 and 1999-2002 NHANES surveys.  These risks will vary with all of the risk 
factors.  To standardize the risk assessment, we present age and sex adjusted risks, using 
the age and sex distribution of the population in 1999-2002 as weights.   
  Table 3 reports the risk profile in the two time periods, for the population as a 
whole and for the near elderly and elderly populations.  For the entire population, the ten 
year mortality risk declined from 9.8 percent in 1971-75 to 8.4 percent in 1999-2002 
(p<.001), an absolute reduction of 1.4 percentage points, and a relative risk reduction of 
14 percent.  Among the population aged 55 and older, the absolute risk fell from 25.7 
percent to 21.7 percent (p<.001), a relative reduction of 16 percent.     12
The lower rows of the table show which risk factor changes were most important 
in this health improvement.  We calculate these by taking derivatives of the prediction 
equation evaluated at the mean risk level [in a logit model, dp/dx = p(1-p)β].  We 
evaluate this equation at the average probability in the population.   
For the population as a whole, the largest risk factor change was the reduction in 
smoking, which contributed to a 0.9 percent absolute decrease in mortality risk.  Better 
risk factor control was second in importance.  Improved blood pressure control led to a 
reduction of 0.6 percent in risk and better cholesterol control accounted for 0.2 percent.  
The increase in obesity offset some, but not all, of these risk reductions. 
In the population aged 55 and older, the patterns were the same, although the 
magnitudes were larger.  The most important factor for the older population was better 
control of medical risk: lower blood pressures contributed a 2.1 percent absolute 
reduction in mortality risk, and lower cholesterol contributed 0.6 percent.  Second in 
importance was decreased smoking, accounting for a 1.2 percent reduction in risk.  
Improved education among the older group led to a nearly 1 percent reduction in risk.  
The impact of obesity was to raise risk by 0.6 percentage points.   
  The factors responsible for better control of hypertension and high cholesterol 
likely include increased use of medications and, to a lesser extent, behavioral change.  
Use of antihypertensive medications rose markedly after the early 1970s (Burt et al., 
1995), and use of HMG-CoA Reductase Inhibitors (i.e. statins) to control cholesterol 
increased markedly in the 1990s (Ma et al., 2005).  Other possible factors include 
reduced fat and salt intake (Cutler and Kadiyala, 2003).    13
  The relatively small impact of obesity on mortality risk is in part a reflection of 
the fact that we control for blood pressure and cholesterol in our mortality equation.  As 
noted above, the estimate of obesity on mortality nearly doubles without controlling for 
these risk factors.  
  Life expectancy is easier to understand than mortality rates.  We simulate the 
impact of risk factor changes by considering how a 14 percent reduction in risk at every 
age would affect mortality rates at each age.  Figure 2 shows the impact.  The lower line 
in the figure is the expected age at death for a person alive at each age, using the 1970 
Social Security life table for the United States.  The upper line is the expected age at 
death for people at those same ages, but with a 14 percent lower mortality rate.  The 
expected increase in longevity is 1.8 years at age 25, 1.6 years at age 45, 1.4 years at age 
65, and 0.7 years at age 85.   
 
IV.  Forecasts of Future Risk 
  Forecasting in any field is difficult, but behaviors are particularly difficult to 
forecast.  Still, forecasting is important in this case for two reasons.  First, we want to 
understand how the disparate trends we have observed will play out in the future.  Will 
the increase in obesity become significant enough to overwhelm reductions in smoking 
and improved risk factor control?  If so, it suggests that longevity forecasts should not be 
as optimistic as they currently are.  Second, forecasting can help evaluate the impact of 
different interventions.  How much would increased use of medications for hypertension 
and high cholesterol mitigate the impact of rising obesity?     14
  We develop a forecasting model based on the pathways laid out in figure 1.  We 
forecast the impact of educational changes and behaviors for the early 2020s, 20 years 
after the most recent NHANES.  As the horizon extends further out, the forecast becomes 
more speculative.   
Our forecasting methodology is explicitly extrapolative.  We want to understand 
what will happen if current trends continue.  This is not a ‘best guess’ about the future 
health profile, which would be based on explicit consideration of the demand for and 
supply of health behavioral changes.  We describe each component of the forecast. 
Education.  We have reasonable data to guide our education simulation, since 
education rarely increases after age 25.  Still, differential mortality by education makes 
the forecast difficult.  For people that will be aged 25-54 in two decades, assume that 
completed education for those ages will match those observed for those same ages in 
1999-2002.  For age and sex groups aged 55 and older, we assume that education will be 
at the highest level for the pre-55 cohorts.  These assumptions yield a 20 year forecast of 
17 percent of people with a high school degree or less (compared to 20 percent in 1999-
2002) and 59 percent of people with at least some college education (compared to 55 
percent currently). 
Smoking.  We also have good data to guide our smoking simulation.  Since people 
rarely start smoking after age 25, the share of elderly people in the future that smoke is 
bounded by the share of people who smoke currently.  Specifically, for people who will 
be age 45 and older in two decades, we assume that the share who will be ever smokers is 
the same as the share for that age and sex group in 1999-2002.  To forecast the division 
between current and former smokers, we use data on the trend in current smoking rates.    15
As shown in Table 2, current smoking rates fell by 2.7 percent per year (demographically 
adjusted) between 1971-75 and 1999-2002.  We assume this rate continues within each 
age and sex group.  We then subtract the forecast of current smokers from the forecast of 
ever smokers to estimate the share of former smokers.   
  For the population 25-44, we do not have past experience to guide our forecasts, 
since we do not view them as adults in 1999-2002.  For these groups, we assume that the 
current smoking rate is equal to the smoking rate in 1999-2002 among that age group, 
adjusted down by 2.7 percent per year (the historical trend).  We assume the same ratio of 
former to current smokers in those age groups as we observe in 1999-2002.  Thus, the 
share of ever smokers is trending down as well.   
  The net impact of our forecast is that current smoking rates would decline from 25 
percent of the population in 1999-2002 to 15 percent two decades later.  The share of 
former smokers would be relatively constant, falling from 26 percent to 23 percent.  
Among the population aged 55 and older, current smoking rates would fall from 16 to 10 
percent, and the share of former smokers would remain constant. 
  It is worth reiterating that our forecast is designed to extrapolate past trends, not 
to provide a best guess about the future.  Still, some data suggest this is reasonable.  
Future generations of Americans will have grown up with stronger warnings about the 
harms from cigarettes than current generations, and may thus smoke less.  In addition, 
recent price increases as a result of tobacco taxes and the Master Settlement Agreement 
should lead additional people to stop smoking (Chaloupka and Warner, 2000).   
  Drinking.  We assume that heavy and light drinking will each change at the same 
annual rate in the next two decades as they did in the period from 1971-75 to 1999-2002   16
(a decline of 1.5 percent per year for heavy drinking and 0.3 percent per year for light 
drinking).  This leads to a forecast of 3.3 percent of the population being heavy drinkers 
in two decades (compared to 4.4 percent currently) and 61.2 percent being light drinkers 
(compared to 65.2 percent currently).   
  Obesity, Hypertension, and High Cholesterol.  Forecasting obesity is difficult, 
since obesity can change rapidly at any age (Cutler, Glaeser, and Shapiro, 2003).  
Further, obesity is a key input into hypertension and high cholesterol, so we cannot 
forecast those without understanding obesity trends.  Our forecast of these factors is done 
in several steps.   
  We start by extrapolating past changes in weight.  Between 1971-75 and 1999-
2002, average BMI increased by 11 percent in total (from 25.6 to 28.3), or 0.4 percent 
annually.  We assume that this annual change in BMI will continue for the next 20 years.  
We account for this by increasing each person’s BMI in the 1999-2002 data uniformly by 
7.4 percent for twenty years.  We then calculate for each person their obesity status:  
underweight, normal weight, overweight, or obese.  This forecast suggests that 0.6 
percent of the population will be underweight (compared to 1.7 percent currently), 20.1 
percent of the population will be normal weight (compared to 30.4 percent currently), 
33.9 percent of the population will be overweight (compared to 34.7 percent currently), 
and 45.4 percent will be obese (compared to 33.2 percent currently).   
  It is important to note a key assumption of this weight forecast.  We assume that 
weight increases by the same percent annually, not the same number of pounds.  An 
increase of the same number of pounds would translate into a reduced growth rate of 
obesity over time.  However, time series data from the Behavioral Risk Factor   17
Surveillance Survey do not show a reduction in the rate of obesity increase in the past 
two decades.  If anything, the rate is increasing over time. 
  The second step is to use these forecasts to simulate the population’s blood 
pressure and cholesterol in two decades if there were no treatment.  To do this, we use 
data from the 1959-62 National Health Examination Survey (NHES).  The NHES data 
were gathered from a period when blood pressure and cholesterol treatments were very 
scarce.  They thus provide a good structural model for these risks.  Following Cutler et al. 
(2007), we relate systolic blood pressure, diastolic blood pressure, and total cholesterol to 
age and age squared, interacted with gender, race dummy variables, and BMI and its 
square.  These regressions are shown in Table 4.  The general fit of the models is good, 
with R
2’s ranging from 24 percent to 37 percent.  The coefficients are all in the expected 
direction; most importantly, BMI is related to blood pressure and cholesterol.   
  We use these equations, and the forecast of BMI for the 1999-2002 population to 
simulate systolic blood pressure, diastolic blood pressure, and total cholesterol.  In 
performing the simulation, we first find the expected value of blood pressure and 
cholesterol for each person.  We then add in a random normal error term, drawn from the 
same variance as in the 1959-62 data.  The latter step allows us to capture heterogeneity 
in actual values of blood pressure and total cholesterol. 
  The next step in the simulation is to consider the impact of treatment.  In our 
benchmark simulation, we assume that treatment will be taken by the same share of 
people and have the same efficacy as medication use does in 1999-2002.  The share of 
people taking medication is known from the 1999-2002 NHANES, which asks explicitly 
about use of anti-hypertensive and cholesterol-lowering medication.  In those data, 60   18
percent of people with hypertension report taking anti-hypertensive medication, and 35 
percent of people with high cholesterol report taking cholesterol-lowering medication.   
For those taking medication, we draw values of blood pressure and cholesterol 
from the distribution of medication users, using the mean and standard deviation of each.  
This simulation suggests that people taking anti-hypertensive medication have a 
reduction of 7.9 (9.2) mmHg in systolic (diastolic) blood pressure (to mean levels of 143 
(89) in systolic (diastolic) blood pressure), and that people taking cholesterol-lowering 
medication have a reduction of 30.5 mg/dL in total cholesterol (to a mean level of 244 
mg/dL).   
These simulations rest on the assumption that the structural equations for blood 
pressure and cholesterol are similar over time.  Consideration of this assumption suggests 
that it is reasonable.  One issue is whether there are other risk factors that would have 
changed over time.  For hypertension, the other likely risk factor is salt intake, but this 
has not changed greatly (Cutler and Kadiyala, 2003).  For cholesterol levels, the share of 
fat and cholesterol in the diet is also important, but this too did not change greatly (Cutler 
and Kadiyala, 2003).  Thus, Cutler et al. (2007) conclude that the early data are a good 
guide to non-treatment blood pressure for the later population, and the same seems likely 
for cholesterol. 
  Table 5 shows the predicted changes in 10 year mortality risk for each of these 
simulations.  We consider the different changes independently, although the effects will 
generally be additive.  Continued reductions in smoking will reduce mortality risk, by 
roughly the same amount as changes over the past thirty years.  The mortality risk for the 
entire population aged 25 and older would decline by 0.7 percent, or 8 percent of the   19
baseline rate.  The impact on the older population would be an absolute mortality 
reduction of 1.0 percent, or 5 percent of the baseline rate.  Education changes would have 
a modest impact on mortality, larger for the older population than for the population as a 
whole. 
  The most surprising finding in table 5 is the impact of future changes in obesity 
on mortality risk.  Even with existing degrees of medication use, the impact of increases 
in obesity, hypertension, and high cholesterol would lead to a 1.1 percent increase in 
mortality risk for the total population, or 13 percent of the baseline rate.  In the 
population 55 and older, the increase in risk is 1.3 percent, or 5 percent of the baseline 
risk.   
The reason for this large impact is the non-linear relationship between BMI and 
weight increase, and between BMI and health risk.  At higher levels of BMI, a given 
percent increase in weight is a greater number of pounds.  And because weights are so 
high to begin with, further increases in weight push many more people into the obese 
category, where health impacts are particularly severe.  Thus, the impact of BMI changes 
on health is becoming increasingly large.   
  Lack of good hypertension and cholesterol control is a major reason why 
increases in BMI have such large impacts on mortality risk.  The last row of the table 
shows an alternative simulation where BMI increases the same amount, but all people 
with hypertension or high cholesterol are assumed to be on medication and medication is 
assumed to bring people to the 75
th percentile of effectiveness.  This is an additional 
reduction of 14 (7) mmHg in systolic (diastolic) blood pressure, and 18 mg/dL in 
cholesterol.  In this simulation, the impact of weight changes on mortality risk is virtually   20
nil, and is significantly smaller than the impact of continued smoking reductions.  The 
key in this simulation is the effectiveness of medications more than getting more people 
to take them.  Because even the typical person taking medication has high risk factor 
levels, increasing the share of people taking medication to 100 percent lowers the risk to 
only 1.0 percent (relative to 1.3 percent at the current level).  If medications can be made 
more effective or used more regularly, however, the benefits would be much greater.  
 
V.   Conclusions 
  The impact of trends in health behaviors on longevity has not been uniform across 
the different behaviors over the past three decades.  Fewer people smoke than used to, but 
more people are obese.  The net impact is important, but not clear a priori.  Examining 
these factors as a whole, we show significant improvements in the health risk profile of 
the U.S. population between the early 1970s and the early 2000s.  Reduced smoking, 
better control of medical risk factors such as hypertension and cholesterol, and better 
education among the older population have been more important for mortality than the 
substantial increase in obesity.   
  Our results suggest substantial caution about the future, however.  Where 
smoking reductions can be expected to have continued impacts on improved health, 
future changes in obesity might more than overwhelm this trend.  Two-thirds of the US 
population is overweight or obese.  As a result, continued increases in weight from 
current levels have a bigger impact on health than did increases in weight from lower 
levels of BMI.  A large part of the impact of BMI is moderated through its effect on 
hypertension and high cholesterol.  Given that not everyone with these conditions takes   21
medications, or is controlled by the medication they do take, the resulting impact of rising 
weight on health can be significant.  The optimistic side of this picture, however, is the 
potential for better control.  If the effectiveness of risk factor control can be increased, 
much of the impact of obesity on mortality risk can be blunted.   
Effectiveness, as we are using the term, captures several factors.  One is the effect 
of the medication when taken as directed.  Studies show that the reduction in blood 
pressure from medication is about the level we predict, and that people taking 
anityhypertensive medication in the NHANES have average blood pressures about the 
level of people treated in clinical trials (e.g., Cushman et al., 2002).  Our predictions of 
cholesterol reduction, in contrast, are only half those in clinical trials (LaRosa et al., 
1999).  Other evidence shows that physicians do not always prescribe evidence-based 
therapies, and not everyone prescribed these medications take them as directed (Lenfant 
2003; Osterberg 2005).  Some people take their medication sporadically, others take only 
part of the dosage, still others take drug ‘holidays’.   
Understanding how to improve utilization of and adherence to recommended 
medications are key issues.  Research has focused on two possible avenues.  The first is 
through performance-based payment.  Physicians are paid for office visits, but not for 
ensuring follow-up with their recommendations.  The idea behind pay-for-performance 
systems is to reward physicians (or insurance companies) for successful efforts to 
increase utilization and possibly adherence.  Such efforts might involve having nurse 
outreach, automatic medication refills, or more convenient office hours to monitor side 
effects.  The second strategy involves use of information technology.  Patients can 
receive electronic reminders about medication goals, information such as blood pressure   22
can be transmitted and monitored electronically, and automated decision tools can help 
with dosing and medication switches.  Whether these or other strategies offer the greatest 
promise of improved adherence is uncertain; our results suggest that evaluating these 
















Figure 1: Conception of Risk Factors Affecting Health  
 



































Table 1: Characteristics of the Sample 
















Female, %  52.5  51.1  54.1  51.9 
Race, %         
   White  89.0  85.8  90.8  88.6 
   Black  10.0  9.9  8.5  8.0 
   Other race  1.0  4.3  0.7  3.5 
Married, %  79.0  64.9  72.5  70.1 
Education, %         
   <High school  34.4  19.8  55.3  31.7 
   High school  37.2  24.9  26.0  27.1 
   At least some college  28.4  55.3  18.6  48.8 
Smoking, %         
   Current smoker  40.3  24.8  28.5  16.3 
   Former smoker  21.2  26.0  27.9  40.6 
   Never smoker  38.5  49.2  43.6  43.1 
Drinking, %         
   Heavy drinker  6.7  4.4  5.8  4.5 
   Light drinker  72.3  65.3  60.3  55.1 
   Non drinker  20.9  30.3  33.9  40.5 
BMI, %         
   Underweight, BMI<18.5  2.8  1.7  2.9  0.9 
   Optimal weight, 18.5≤BMI<25 47.7  30.4  40.1  25.0 
   Overweight, 25≤BMI<30 34.6  34.7 37.5  36.4 
   Obese, 30≤BMI 14.8  33.2  19.5  37.7 
Blood Pressure, %         
   Normal blood pressure  22.4  43.4  8.9  22.5 
   Pre-hypertension  38.2  38.9  28.1  43.6 
   Stage 1 hypertension  23.6  13.1  32.4  22.3 
   Stage 2 hypertension  15.7  4.6  30.6  11.7 
Cholesterol, %         
   Normal cholesterol  35.4  47.4  19.6  35.6 
   Borderline high  34.9  34.4  34.7  41.8 
   High  29.7  18.3  45.7  22.6 





Table 2: Effect of Risk Factors on 10 Year Mortality 
Variable  Odds Ratio  Standard error 
Race (relative to white)     
  Black  1.402
** .195 
  Other race  .245  .221 
Married .682
** .077 
Education (relative to high school graduate) 
  <High School  1.269
** .144 
  At Least Some College  1.062  .191 
Smoking status (relative to never smoker) 
  Current smoker  2.126
** .250 
  Former smoker  1.233  .165 
Drinking status (relative to never drinker) 
  Heavy drinker  1.021  .175 
  Light drinker  .771
** .094 
BMI (relative to optimal) 
  Underweight, BMI<18.5  2.408
** .582 
  Overweight, 25≤BMI<30 .762
** .089 
  Obese, BMI≥30 1.278  .197 
Blood pressure (relative to normal) 
   Pre-hypertension  .904  .166 
   Stage 1 hypertension  1.131  .201 
   Stage 2 hypertension  1.535
** .289 
Cholesterol (relative to normal) 
   Borderline high  1.029  .130 
   High  1.150  .148 
N 6,525 
Note: Data are from NHANES I.  The regression includes 10 






Table 3: Impact of Risk Factors on Predicted 10-Year Mortality  
  Total Population  Population 55+ 
Predicted mortality, 1971-75  9.8%  25.7% 
Predicted mortality, 1999-02  8.4  21.7 
Change -1.4  -3.9 
Effect of:     
   Smoking  -0.9  -1.2 
   Blood pressure  -0.6  -2.1 
   Education  -0.2  -0.9 
   Cholesterol  -0.2  -0.6 
   Drinking  0.1  0.2 
   BMI  0.3  0.6 
Note: Estimates are adjusted to the age and sex distribution of the 
population in 1999-2002.  Effects of changes in race and marital 






Table 4: Prediction Equations for Blood Pressure and 
Cholesterol  
 Blood  Pressure   
           
Systolic 



























































































N 6,257  6,257  6,098 
R
2 .373  .240  .244 
Note: Data are from the 1959-62 National Health 





Table 5: Impact of Possible Future Risk Factors on Predicted 10-









   Continued reduction in smoking  -0.7  -1.0 
   Continued increase in education  0.0  -0.5 
   Continued reduction in drinking  0.1  0.2 
   Continued increase in obesity  1.1  1.3 
   Continued increase in obesity and  
      more effective medications 
0.0 0.1 
 
Note: Estimates are adjusted to the age and sex distribution of the 
population in 1999-2002.  Effects of changes in race and marital 
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